Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: padco who wrote (13640)	9/24/2004 10:12:32 AM
From: axial	Respond to of 14101

Padco, the only reason to invest in any stock is the possibility of appreciation. You and Dave have valid reasons for not investing. Let me throw more reasons into the pot: we all know there's a financing coming up. The price will drop. If one were to buy, that would be when to do it. Obviously, management change has caused some holders to sell out - and that may well include some PIPE investors. One should wait for the stock to settle down. You and Dave say Dimethaid isn't a good enough investment for you. Fine. I simply stated the other side of the story. That's what makes a market. Jim

To: padco who wrote (13640)	9/24/2004 12:17:54 PM
From: DaveAu	Respond to of 14101

Thank you Padco. That is exactly what I meant. I never said "no possibility" as Jim seemed to think but I did mean that the probability of an FDA approval prior to massive dilution seemed very low. There is a possibility that I might get rich from buying a lotter ticket but I don't consider it to be a good investment. Dave

To: padco who wrote (13640)	9/24/2004 10:37:05 PM
From: axial	Read Replies (1) \| Respond to of 14101

Padco, investors play stocks for different reasons. You and Dave share a negative view, and I don't know how I could have been clearer in respecting those views. Investor sentiment is bad - and it may get worse as the realities become clearer. However, you and Dave don't represent all the views. As negative and cautious as you may be about the stock - and I repeat again that those views are understood - there are other views that see this as a speculative opportunity: a chance to buy when "blood is running in the streets", as the saying goes. Apparently you and Dave would prefer uninterrupted promotion of negativity. Please pardon the different point of view. You're both completely and absolutely right. There is no valid reason for any investor to buy Dimethaid at present. What could those silly players, who bought over 400,000 shares today, be thinking? Shame on us. Jim